The global Assisted Reproductive Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Ovulation Stimulation Drugs Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Assisted Reproductive Drugs include Merck Serono, MSD, Livzon Pharmaceutical, Xianju Pharmaceutical and Kinsey Pharmaceuticals, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Assisted reproductive drugs include ovulation-stimulating drugs, luteal support drugs, down-regulatory drugs, ovulation-inducing drugs, etc. From the perspective of the use of various drugs in the IVF process, ovulation-stimulating drugs accounted for the highest proportion, as high as 62%, luteal support drugs accounted for 20%, down-regulatory drugs accounted for 15%, and ovulation-inducing drugs accounted for 3%.
This report aims to provide a comprehensive presentation of the global market for Assisted Reproductive Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Assisted Reproductive Drugs. This report contains market size and forecasts of Assisted Reproductive Drugs in global, including the following market information:
- Global Assisted Reproductive Drugs Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global Assisted Reproductive Drugs Market Sales, 2019-2024, 2025-2030, (K Units)
- Global top five Assisted Reproductive Drugs companies in 2023 (%)
We surveyed the Assisted Reproductive Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Assisted Reproductive Drugs Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Assisted Reproductive Drugs Market Segment Percentages, by Type, 2023 (%)
- Ovulation Stimulation Drugs
- Luteal Support Medications
- Downregulatory Drugs
- Ovulation Inducing Drugs
Global Assisted Reproductive Drugs Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Assisted Reproductive Drugs Market Segment Percentages, by Application, 2023 (%)
- Hospital
- Medical Institutions
- Research Institute
- Others
Global Assisted Reproductive Drugs Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Assisted Reproductive Drugs Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Assisted Reproductive Drugs revenues in global market, 2019-2024 (Estimated), ($ millions)
- Key companies Assisted Reproductive Drugs revenues share in global market, 2023 (%)
- Key companies Assisted Reproductive Drugs sales in global market, 2019-2024 (Estimated), (K Units)
- Key companies Assisted Reproductive Drugs sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merck Serono
- MSD
- Livzon Pharmaceutical
- Xianju Pharmaceutical
- Kinsey Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Assisted Reproductive Drugs, market overview.
Chapter 2: Global Assisted Reproductive Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Assisted Reproductive Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Assisted Reproductive Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Assisted Reproductive Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Assisted Reproductive Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Assisted Reproductive Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Assisted Reproductive Drugs Overall Market Size
2.1 Global Assisted Reproductive Drugs Market Size: 2023 VS 2030
2.2 Global Assisted Reproductive Drugs Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Assisted Reproductive Drugs Sales: 2019-2030
3 Company Landscape
3.1 Top Assisted Reproductive Drugs Players in Global Market
3.2 Top Global Assisted Reproductive Drugs Companies Ranked by Revenue
3.3 Global Assisted Reproductive Drugs Revenue by Companies
3.4 Global Assisted Reproductive Drugs Sales by Companies
3.5 Global Assisted Reproductive Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Assisted Reproductive Drugs Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Assisted Reproductive Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Assisted Reproductive Drugs Players in Global Market
3.8.1 List of Global Tier 1 Assisted Reproductive Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Assisted Reproductive Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Assisted Reproductive Drugs Market Size Markets, 2023 & 2030
4.1.2 Ovulation Stimulation Drugs
4.1.3 Luteal Support Medications
4.1.4 Downregulatory Drugs
4.1.5 Ovulation Inducing Drugs
4.2 By Type - Global Assisted Reproductive Drugs Revenue & Forecasts
4.2.1 By Type - Global Assisted Reproductive Drugs Revenue, 2019-2024
4.2.2 By Type - Global Assisted Reproductive Drugs Revenue, 2025-2030
4.2.3 By Type - Global Assisted Reproductive Drugs Revenue Market Share, 2019-2030
4.3 By Type - Global Assisted Reproductive Drugs Sales & Forecasts
4.3.1 By Type - Global Assisted Reproductive Drugs Sales, 2019-2024
4.3.2 By Type - Global Assisted Reproductive Drugs Sales, 2025-2030
4.3.3 By Type - Global Assisted Reproductive Drugs Sales Market Share, 2019-2030
4.4 By Type - Global Assisted Reproductive Drugs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Assisted Reproductive Drugs Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Medical Institutions
5.1.4 Research Institute
5.1.5 Others
5.2 By Application - Global Assisted Reproductive Drugs Revenue & Forecasts
5.2.1 By Application - Global Assisted Reproductive Drugs Revenue, 2019-2024
5.2.2 By Application - Global Assisted Reproductive Drugs Revenue, 2025-2030
5.2.3 By Application - Global Assisted Reproductive Drugs Revenue Market Share, 2019-2030
5.3 By Application - Global Assisted Reproductive Drugs Sales & Forecasts
5.3.1 By Application - Global Assisted Reproductive Drugs Sales, 2019-2024
5.3.2 By Application - Global Assisted Reproductive Drugs Sales, 2025-2030
5.3.3 By Application - Global Assisted Reproductive Drugs Sales Market Share, 2019-2030
5.4 By Application - Global Assisted Reproductive Drugs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Assisted Reproductive Drugs Market Size, 2023 & 2030
6.2 By Region - Global Assisted Reproductive Drugs Revenue & Forecasts
6.2.1 By Region - Global Assisted Reproductive Drugs Revenue, 2019-2024
6.2.2 By Region - Global Assisted Reproductive Drugs Revenue, 2025-2030
6.2.3 By Region - Global Assisted Reproductive Drugs Revenue Market Share, 2019-2030
6.3 By Region - Global Assisted Reproductive Drugs Sales & Forecasts
6.3.1 By Region - Global Assisted Reproductive Drugs Sales, 2019-2024
6.3.2 By Region - Global Assisted Reproductive Drugs Sales, 2025-2030
6.3.3 By Region - Global Assisted Reproductive Drugs Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Assisted Reproductive Drugs Revenue, 2019-2030
6.4.2 By Country - North America Assisted Reproductive Drugs Sales, 2019-2030
6.4.3 US Assisted Reproductive Drugs Market Size, 2019-2030
6.4.4 Canada Assisted Reproductive Drugs Market Size, 2019-2030
6.4.5 Mexico Assisted Reproductive Drugs Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Assisted Reproductive Drugs Revenue, 2019-2030
6.5.2 By Country - Europe Assisted Reproductive Drugs Sales, 2019-2030
6.5.3 Germany Assisted Reproductive Drugs Market Size, 2019-2030
6.5.4 France Assisted Reproductive Drugs Market Size, 2019-2030
6.5.5 U.K. Assisted Reproductive Drugs Market Size, 2019-2030
6.5.6 Italy Assisted Reproductive Drugs Market Size, 2019-2030
6.5.7 Russia Assisted Reproductive Drugs Market Size, 2019-2030
6.5.8 Nordic Countries Assisted Reproductive Drugs Market Size, 2019-2030
6.5.9 Benelux Assisted Reproductive Drugs Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Assisted Reproductive Drugs Revenue, 2019-2030
6.6.2 By Region - Asia Assisted Reproductive Drugs Sales, 2019-2030
6.6.3 China Assisted Reproductive Drugs Market Size, 2019-2030
6.6.4 Japan Assisted Reproductive Drugs Market Size, 2019-2030
6.6.5 South Korea Assisted Reproductive Drugs Market Size, 2019-2030
6.6.6 Southeast Asia Assisted Reproductive Drugs Market Size, 2019-2030
6.6.7 India Assisted Reproductive Drugs Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Assisted Reproductive Drugs Revenue, 2019-2030
6.7.2 By Country - South America Assisted Reproductive Drugs Sales, 2019-2030
6.7.3 Brazil Assisted Reproductive Drugs Market Size, 2019-2030
6.7.4 Argentina Assisted Reproductive Drugs Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Assisted Reproductive Drugs Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Assisted Reproductive Drugs Sales, 2019-2030
6.8.3 Turkey Assisted Reproductive Drugs Market Size, 2019-2030
6.8.4 Israel Assisted Reproductive Drugs Market Size, 2019-2030
6.8.5 Saudi Arabia Assisted Reproductive Drugs Market Size, 2019-2030
6.8.6 UAE Assisted Reproductive Drugs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Merck Serono
7.1.1 Merck Serono Company Summary
7.1.2 Merck Serono Business Overview
7.1.3 Merck Serono Assisted Reproductive Drugs Major Product Offerings
7.1.4 Merck Serono Assisted Reproductive Drugs Sales and Revenue in Global (2019-2024)
7.1.5 Merck Serono Key News & Latest Developments
7.2 MSD
7.2.1 MSD Company Summary
7.2.2 MSD Business Overview
7.2.3 MSD Assisted Reproductive Drugs Major Product Offerings
7.2.4 MSD Assisted Reproductive Drugs Sales and Revenue in Global (2019-2024)
7.2.5 MSD Key News & Latest Developments
7.3 Livzon Pharmaceutical
7.3.1 Livzon Pharmaceutical Company Summary
7.3.2 Livzon Pharmaceutical Business Overview
7.3.3 Livzon Pharmaceutical Assisted Reproductive Drugs Major Product Offerings
7.3.4 Livzon Pharmaceutical Assisted Reproductive Drugs Sales and Revenue in Global (2019-2024)
7.3.5 Livzon Pharmaceutical Key News & Latest Developments
7.4 Xianju Pharmaceutical
7.4.1 Xianju Pharmaceutical Company Summary
7.4.2 Xianju Pharmaceutical Business Overview
7.4.3 Xianju Pharmaceutical Assisted Reproductive Drugs Major Product Offerings
7.4.4 Xianju Pharmaceutical Assisted Reproductive Drugs Sales and Revenue in Global (2019-2024)
7.4.5 Xianju Pharmaceutical Key News & Latest Developments
7.5 Kinsey Pharmaceuticals
7.5.1 Kinsey Pharmaceuticals Company Summary
7.5.2 Kinsey Pharmaceuticals Business Overview
7.5.3 Kinsey Pharmaceuticals Assisted Reproductive Drugs Major Product Offerings
7.5.4 Kinsey Pharmaceuticals Assisted Reproductive Drugs Sales and Revenue in Global (2019-2024)
7.5.5 Kinsey Pharmaceuticals Key News & Latest Developments
8 Global Assisted Reproductive Drugs Production Capacity, Analysis
8.1 Global Assisted Reproductive Drugs Production Capacity, 2019-2030
8.2 Assisted Reproductive Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Assisted Reproductive Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Assisted Reproductive Drugs Supply Chain Analysis
10.1 Assisted Reproductive Drugs Industry Value Chain
10.2 Assisted Reproductive Drugs Upstream Market
10.3 Assisted Reproductive Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Assisted Reproductive Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Assisted Reproductive Drugs in Global Market
Table 2. Top Assisted Reproductive Drugs Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Assisted Reproductive Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Assisted Reproductive Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Assisted Reproductive Drugs Sales by Companies, (K Units), 2019-2024
Table 6. Global Assisted Reproductive Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Assisted Reproductive Drugs Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Assisted Reproductive Drugs Product Type
Table 9. List of Global Tier 1 Assisted Reproductive Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Assisted Reproductive Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Assisted Reproductive Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Assisted Reproductive Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Assisted Reproductive Drugs Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Assisted Reproductive Drugs Sales (K Units), 2019-2024
Table 15. By Type - Global Assisted Reproductive Drugs Sales (K Units), 2025-2030
Table 16. By Application ? Global Assisted Reproductive Drugs Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Assisted Reproductive Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Assisted Reproductive Drugs Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Assisted Reproductive Drugs Sales (K Units), 2019-2024
Table 20. By Application - Global Assisted Reproductive Drugs Sales (K Units), 2025-2030
Table 21. By Region ? Global Assisted Reproductive Drugs Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Assisted Reproductive Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Assisted Reproductive Drugs Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Assisted Reproductive Drugs Sales (K Units), 2019-2024
Table 25. By Region - Global Assisted Reproductive Drugs Sales (K Units), 2025-2030
Table 26. By Country - North America Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Assisted Reproductive Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Assisted Reproductive Drugs Sales, (K Units), 2019-2024
Table 29. By Country - North America Assisted Reproductive Drugs Sales, (K Units), 2025-2030
Table 30. By Country - Europe Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Assisted Reproductive Drugs Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Assisted Reproductive Drugs Sales, (K Units), 2019-2024
Table 33. By Country - Europe Assisted Reproductive Drugs Sales, (K Units), 2025-2030
Table 34. By Region - Asia Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Assisted Reproductive Drugs Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Assisted Reproductive Drugs Sales, (K Units), 2019-2024
Table 37. By Region - Asia Assisted Reproductive Drugs Sales, (K Units), 2025-2030
Table 38. By Country - South America Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Assisted Reproductive Drugs Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Assisted Reproductive Drugs Sales, (K Units), 2019-2024
Table 41. By Country - South America Assisted Reproductive Drugs Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Assisted Reproductive Drugs Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Assisted Reproductive Drugs Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Assisted Reproductive Drugs Sales, (K Units), 2025-2030
Table 46. Merck Serono Company Summary
Table 47. Merck Serono Assisted Reproductive Drugs Product Offerings
Table 48. Merck Serono Assisted Reproductive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Merck Serono Key News & Latest Developments
Table 50. MSD Company Summary
Table 51. MSD Assisted Reproductive Drugs Product Offerings
Table 52. MSD Assisted Reproductive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. MSD Key News & Latest Developments
Table 54. Livzon Pharmaceutical Company Summary
Table 55. Livzon Pharmaceutical Assisted Reproductive Drugs Product Offerings
Table 56. Livzon Pharmaceutical Assisted Reproductive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Livzon Pharmaceutical Key News & Latest Developments
Table 58. Xianju Pharmaceutical Company Summary
Table 59. Xianju Pharmaceutical Assisted Reproductive Drugs Product Offerings
Table 60. Xianju Pharmaceutical Assisted Reproductive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Xianju Pharmaceutical Key News & Latest Developments
Table 62. Kinsey Pharmaceuticals Company Summary
Table 63. Kinsey Pharmaceuticals Assisted Reproductive Drugs Product Offerings
Table 64. Kinsey Pharmaceuticals Assisted Reproductive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Kinsey Pharmaceuticals Key News & Latest Developments
Table 66. Assisted Reproductive Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 67. Global Assisted Reproductive Drugs Capacity Market Share of Key Manufacturers, 2022-2024
Table 68. Global Assisted Reproductive Drugs Production by Region, 2019-2024 (K Units)
Table 69. Global Assisted Reproductive Drugs Production by Region, 2025-2030 (K Units)
Table 70. Assisted Reproductive Drugs Market Opportunities & Trends in Global Market
Table 71. Assisted Reproductive Drugs Market Drivers in Global Market
Table 72. Assisted Reproductive Drugs Market Restraints in Global Market
Table 73. Assisted Reproductive Drugs Raw Materials
Table 74. Assisted Reproductive Drugs Raw Materials Suppliers in Global Market
Table 75. Typical Assisted Reproductive Drugs Downstream
Table 76. Assisted Reproductive Drugs Downstream Clients in Global Market
Table 77. Assisted Reproductive Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Assisted Reproductive Drugs Segment by Type in 2023
Figure 2. Assisted Reproductive Drugs Segment by Application in 2023
Figure 3. Global Assisted Reproductive Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Assisted Reproductive Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Assisted Reproductive Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. Assisted Reproductive Drugs Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Assisted Reproductive Drugs Revenue in 2023
Figure 9. By Type - Global Assisted Reproductive Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Assisted Reproductive Drugs Revenue Market Share, 2019-2030
Figure 11. By Type - Global Assisted Reproductive Drugs Sales Market Share, 2019-2030
Figure 12. By Type - Global Assisted Reproductive Drugs Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Assisted Reproductive Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Assisted Reproductive Drugs Revenue Market Share, 2019-2030
Figure 15. By Application - Global Assisted Reproductive Drugs Sales Market Share, 2019-2030
Figure 16. By Application - Global Assisted Reproductive Drugs Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Assisted Reproductive Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Assisted Reproductive Drugs Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Assisted Reproductive Drugs Revenue Market Share, 2019-2030
Figure 20. By Region - Global Assisted Reproductive Drugs Sales Market Share, 2019-2030
Figure 21. By Country - North America Assisted Reproductive Drugs Revenue Market Share, 2019-2030
Figure 22. By Country - North America Assisted Reproductive Drugs Sales Market Share, 2019-2030
Figure 23. US Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Assisted Reproductive Drugs Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Assisted Reproductive Drugs Sales Market Share, 2019-2030
Figure 28. Germany Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. France Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Assisted Reproductive Drugs Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Assisted Reproductive Drugs Sales Market Share, 2019-2030
Figure 37. China Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. India Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Assisted Reproductive Drugs Revenue Market Share, 2019-2030
Figure 43. By Country - South America Assisted Reproductive Drugs Sales Market Share, 2019-2030
Figure 44. Brazil Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Assisted Reproductive Drugs Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Assisted Reproductive Drugs Sales Market Share, 2019-2030
Figure 48. Turkey Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Assisted Reproductive Drugs Revenue, (US$, Mn), 2019-2030
Figure 52. Global Assisted Reproductive Drugs Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Assisted Reproductive Drugs by Region, 2023 VS 2030
Figure 54. Assisted Reproductive Drugs Industry Value Chain
Figure 55. Marketing Channels
